FDA curbs use of antibody drugs sidelined by omicron... KBTV | 2022-01-24 23:02 UTC COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for nearly all U. S. infections, U. S. health regulators said Monday. The Food and Drug Administr